首页 > 最新文献

Toxicology最新文献

英文 中文
Cx43 phosphorylation at Ser368 facilitates PASMC dedifferentiation in nicotine-induced pulmonary arterial remodeling Cx43 Ser368位点磷酸化促进尼古丁诱导的肺动脉重构中PASMC去分化。
IF 4.6 3区 医学 Q1 PHARMACOLOGY & PHARMACY Pub Date : 2025-12-30 DOI: 10.1016/j.tox.2025.154389
Yi Xu , Xiaomin Hou , Su Guo , Jin Zhou , Xuelu Jiang , Zhifa Zheng , Liangyuan Zhao , Xiaoxia Ren , Lingbo Yang , Yiwei Shi , Xiaojiang Qin

Background

Pulmonary arterial hypertension is a severe disease characterized by pulmonary vascular remodeling, which is closely associated with the phenotypic switching of pulmonary artery smooth muscle cells (PASMCs). Connexin 43 (Cx43) phosphorylation is a key regulator of intercellular communication. However, the specific mechanism underlying nicotine-induced dedifferentiation of PASMCs remains unclear.

Purpose

This study aimed to investigate the molecular mechanism by which Cx43 phosphorylation promotes nicotine-induced phenotypic switching of PASMCs, thereby driving pulmonary vascular remodeling.

Methods

Using Tagln-Cre; Cx43+ /+ and Tagln-Cre; Cx43flox/+ deletion mice exposed to nicotine, a series of in vivo and in vitro experiments were conducted to investigate the mechanism by which nicotine promotes pulmonary arterial remodeling via protein kinase C-mediated phosphorylation of Cx43 and subsequent dedifferentiation of PASMCs. The involvement of this kinase pathway was further validated with its specific inhibitor, chelerythrine chloride.

Results

Nicotine increased PASMC dedifferentiation by promoting Cx43 phosphorylation at Ser368 (Cx43-pS368). In Tagln-Cre; Cx43 flox/+ mice, these pathological changes were reduced. In vitro, chelerythrine chloride was utilized to inhibit nicotine-induced Cx43-pS368. This suppression of Cx43-pS368 effectively attenuated nicotine-induced PASMC dedifferentiation, thereby ameliorating pulmonary arterial remodeling.

Conclusion

Nicotine can induce PASMC phenotypic transformation by modulating Cx43-pS368, thereby promoting pulmonary artery remodeling. Targeting this pathway could provide a therapeutic strategy for nicotine-related pulmonary vascular diseases.
背景:肺动脉高压是一种以肺血管重构为特征的严重疾病,与肺动脉平滑肌细胞(PASMCs)的表型转换密切相关。连接蛋白43 (Cx43)磷酸化是细胞间通讯的关键调节因子。然而,尼古丁诱导PASMCs去分化的具体机制尚不清楚。目的:本研究旨在探讨Cx43磷酸化促进尼古丁诱导的PASMCs表型转换,从而驱动肺血管重构的分子机制。方法:taglen - cre;Cx43+/+和Tagln-Cre;通过对暴露于尼古丁的Cx43flox/+缺失小鼠进行一系列体内和体外实验,探讨尼古丁通过蛋白激酶c介导的Cx43磷酸化和随后的PASMCs去分化促进肺动脉重塑的机制。这种激酶途径的参与通过其特异性抑制剂氯化chelerythrine进一步验证。结果:尼古丁通过促进Cx43 Ser368位点的磷酸化(Cx43- ps368)增加PASMC去分化。在Tagln-Cre;Cx43flox/+小鼠,这些病理改变减轻。在体外,利用氯化chelerythrine抑制尼古丁诱导的Cx43-pS368。这种对Cx43-pS368的抑制有效地减弱了尼古丁诱导的PASMC去分化,从而改善了肺动脉重塑。结论:尼古丁可通过调节Cx43-pS368诱导PASMC表型转化,从而促进肺动脉重塑。靶向这一途径可能为尼古丁相关肺血管疾病提供一种治疗策略。
{"title":"Cx43 phosphorylation at Ser368 facilitates PASMC dedifferentiation in nicotine-induced pulmonary arterial remodeling","authors":"Yi Xu ,&nbsp;Xiaomin Hou ,&nbsp;Su Guo ,&nbsp;Jin Zhou ,&nbsp;Xuelu Jiang ,&nbsp;Zhifa Zheng ,&nbsp;Liangyuan Zhao ,&nbsp;Xiaoxia Ren ,&nbsp;Lingbo Yang ,&nbsp;Yiwei Shi ,&nbsp;Xiaojiang Qin","doi":"10.1016/j.tox.2025.154389","DOIUrl":"10.1016/j.tox.2025.154389","url":null,"abstract":"<div><h3>Background</h3><div>Pulmonary arterial hypertension is a severe disease characterized by pulmonary vascular remodeling, which is closely associated with the phenotypic switching of pulmonary artery smooth muscle cells (PASMCs). Connexin 43 (Cx43) phosphorylation is a key regulator of intercellular communication. However, the specific mechanism underlying nicotine-induced dedifferentiation of PASMCs remains unclear.</div></div><div><h3>Purpose</h3><div>This study aimed to investigate the molecular mechanism by which Cx43 phosphorylation promotes nicotine-induced phenotypic switching of PASMCs, thereby driving pulmonary vascular remodeling.</div></div><div><h3>Methods</h3><div>Using <em>Tagln-Cre; Cx43</em><sup><em>+ /+</em></sup> and <em>Tagln-Cre; Cx43</em><sup><em>flox/+</em></sup> deletion mice exposed to nicotine, a series of <em>in vivo</em> and <em>in vitro</em> experiments were conducted to investigate the mechanism by which nicotine promotes pulmonary arterial remodeling via protein kinase C-mediated phosphorylation of Cx43 and subsequent dedifferentiation of PASMCs. The involvement of this kinase pathway was further validated with its specific inhibitor, chelerythrine chloride.</div></div><div><h3>Results</h3><div>Nicotine increased PASMC dedifferentiation by promoting Cx43 phosphorylation at Ser368 (Cx43-pS368). In <em>Tagln-Cre; Cx43</em> <sup><em>flox/+</em></sup> mice, these pathological changes were reduced. In vitro, chelerythrine chloride was utilized to inhibit nicotine-induced Cx43-pS368. This suppression of Cx43-pS368 effectively attenuated nicotine-induced PASMC dedifferentiation, thereby ameliorating pulmonary arterial remodeling.</div></div><div><h3>Conclusion</h3><div>Nicotine can induce PASMC phenotypic transformation by modulating Cx43-pS368, thereby promoting pulmonary artery remodeling. Targeting this pathway could provide a therapeutic strategy for nicotine-related pulmonary vascular diseases.</div></div>","PeriodicalId":23159,"journal":{"name":"Toxicology","volume":"521 ","pages":"Article 154389"},"PeriodicalIF":4.6,"publicationDate":"2025-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145889886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Macrophage-epithelial cells crosstalk and the role of CCL2-CCR2 axis in single-walled carbon nanotubes-induced lung inflammation and fibrosis 巨噬细胞-上皮细胞串扰及CCL2-CCR2轴在单壁碳纳米管诱导的肺部炎症和纤维化中的作用
IF 4.6 3区 医学 Q1 PHARMACOLOGY & PHARMACY Pub Date : 2025-12-27 DOI: 10.1016/j.tox.2025.154388
Yalu Shen , Zhen Shi , Jiayang Zou , Yunfei Zhou , Qingqing Yang , Wenrui Zhao , Yu Gan , Xinxin Hu , Tong Shen , Xiang Zhang
Environmental and occupational exposure to carbon nanotube (CNT) raises concerns over their safety and adverse health impacts, especially lung inflammation and fibrosis. Immune cells and epithelial cells within alveoli interact with each other to maintain lung homeostasis. To date, the contribution of lung macrophage-epithelial cells crosstalk to single-walled CNT (SWCNT)-caused lung injury and underlying mechanisms have not been systematically investigated. Here, we established a mice model of lung exposure to SWCNT and found that SWCNT induced M1-typed lung macrophages polarization during inflammation stage and abnormal epithelium regeneration during fibrosis stage, characterized by impaired alveolar epithelial type Ⅱ (AT2) cells to alveolar epithelial type Ⅰ (AT1) cells transition. Mechanistically, conditioned medium experiments combined with chemokines CCL2 siRNA intervene revealed that damaged lung epithelial cells-derived CCL2 by SWCNT activated CCR2 in macrophages, subsequently polarizing to M1 state. In vivo experiments further demonstrated CCL2-CCR2 axis regulated SWCNT-polarized M1 lung macrophages and pro-inflammatory cytokines secretion, which are involved in the impairment of AT2-AT1 cells transition. Importantly, inhibition of CCL2-CCR2 axis effectively restored SWCNT-induced lung inflammation and fibrosis. In conclusion, our findings elucidate the crosstalk of lung macrophages and epithelial cells, which further regulates the progression of SWCNT-induced lung injury, and target CCL2-CCR2 axis is expected to be potential therapeutic strategy for the prevention and treatment of lung injury induced by nanoparticles.
环境和职业暴露于碳纳米管(CNT)引起了对其安全性和不良健康影响的担忧,特别是肺部炎症和纤维化。肺泡内的免疫细胞和上皮细胞相互作用,维持肺内稳态。迄今为止,肺巨噬细胞-上皮细胞串扰对单壁碳纳米管(SWCNT)引起的肺损伤的贡献及其潜在机制尚未得到系统的研究。在这里,我们建立了肺暴露于SWCNT的小鼠模型,发现SWCNT在炎症阶段诱导m1型肺巨噬细胞极化,在纤维化阶段诱导异常上皮再生,其特征是肺泡上皮型Ⅱ(AT2)细胞受损向肺泡上皮型Ⅰ(AT1)细胞转变。在机制上,条件培养基实验结合趋化因子CCL2 siRNA干预显示,受损肺上皮细胞来源的CCL2通过SWCNT激活巨噬细胞中的CCR2,随后极化到M1状态。体内实验进一步证实CCL2-CCR2轴调控swcnts极化M1肺巨噬细胞和促炎细胞因子分泌,参与AT2-AT1细胞转化的损伤。重要的是,抑制CCL2-CCR2轴可有效恢复swcnts诱导的肺部炎症和纤维化。综上所述,我们的研究结果阐明了肺巨噬细胞和上皮细胞的串扰,从而进一步调控swcnts诱导的肺损伤的进展,靶向CCL2-CCR2轴有望成为预防和治疗纳米颗粒诱导的肺损伤的潜在治疗策略。
{"title":"Macrophage-epithelial cells crosstalk and the role of CCL2-CCR2 axis in single-walled carbon nanotubes-induced lung inflammation and fibrosis","authors":"Yalu Shen ,&nbsp;Zhen Shi ,&nbsp;Jiayang Zou ,&nbsp;Yunfei Zhou ,&nbsp;Qingqing Yang ,&nbsp;Wenrui Zhao ,&nbsp;Yu Gan ,&nbsp;Xinxin Hu ,&nbsp;Tong Shen ,&nbsp;Xiang Zhang","doi":"10.1016/j.tox.2025.154388","DOIUrl":"10.1016/j.tox.2025.154388","url":null,"abstract":"<div><div>Environmental and occupational exposure to carbon nanotube (CNT) raises concerns over their safety and adverse health impacts, especially lung inflammation and fibrosis. Immune cells and epithelial cells within alveoli interact with each other to maintain lung homeostasis. To date, the contribution of lung macrophage-epithelial cells crosstalk to single-walled CNT (SWCNT)-caused lung injury and underlying mechanisms have not been systematically investigated. Here, we established a mice model of lung exposure to SWCNT and found that SWCNT induced M1-typed lung macrophages polarization during inflammation stage and abnormal epithelium regeneration during fibrosis stage, characterized by impaired alveolar epithelial type Ⅱ (AT2) cells to alveolar epithelial type Ⅰ (AT1) cells transition. Mechanistically, conditioned medium experiments combined with chemokines CCL2 siRNA intervene revealed that damaged lung epithelial cells-derived CCL2 by SWCNT activated CCR2 in macrophages, subsequently polarizing to M1 state. <em>In vivo</em> experiments further demonstrated CCL2-CCR2 axis regulated SWCNT-polarized M1 lung macrophages and pro-inflammatory cytokines secretion, which are involved in the impairment of AT2-AT1 cells transition. Importantly, inhibition of CCL2-CCR2 axis effectively restored SWCNT-induced lung inflammation and fibrosis. In conclusion, our findings elucidate the crosstalk of lung macrophages and epithelial cells, which further regulates the progression of SWCNT-induced lung injury, and target CCL2-CCR2 axis is expected to be potential therapeutic strategy for the prevention and treatment of lung injury induced by nanoparticles.</div></div>","PeriodicalId":23159,"journal":{"name":"Toxicology","volume":"521 ","pages":"Article 154388"},"PeriodicalIF":4.6,"publicationDate":"2025-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145858130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PPAR subtypes determine distinct modes of action of phthalate esters (PAEs) and per- and polyfluoroalkyl substances (PFAS) in disrupting human macrophage alternative activation PPAR亚型决定了邻苯二甲酸酯(PAEs)和全氟烷基和多氟烷基物质(PFAS)在破坏人巨噬细胞替代激活中的不同作用模式。
IF 4.6 3区 医学 Q1 PHARMACOLOGY & PHARMACY Pub Date : 2025-12-26 DOI: 10.1016/j.tox.2025.154387
Zhisen Zhuang , Lijuan You , Jianbo Kong , Yaru Tian , Yongning Li , Yuan Zhi , Bo Zhang , Yi Wan , Xudong Jia , Hui Yang
Phthalate esters (PAEs) and per- and polyfluoroalkyl substances (PFAS) are ubiquitous pollutants tied to metabolic and immune disorders. The peroxisome proliferator-activated receptor (PPAR) pathway has been indicated to mediate their toxic effects, but the specific functions of PPAR subtypes and their mediating roles remain unclear. In this study, we generated PPARα-, δ-, and γ-specific knockout THP-1 cell lines by using CRISPR/Cas9 system and then differentiated them into interleukin-4 (IL-4) and interleukin-13 (IL-13)-polarized macrophages (alternative activation). During the induction process, the cells were exposed to 0, 6.25, 12.5, 25, 50, 100 μM of five PAE metabolites: Mono-(2-ethylhexyl) phthalate (MEHP), Monocyclohexyl phthalate (MCHP), Monoisonyl phthalate (MINP), Monoisobutyl phthalate (MIBP), and Monobenzyl phthalate (MBzP); and five PFAS: Perfluoroundecanoic acid (PFUnDA), Perfluorodecanoic acid (PFDA), Perfluorooctanoic acid (PFOA), Potassium perfluorooctanesulfonate (PFOS-K), and Potassium 9-chlorohexadecafluoro-3-oxanonane-1-sulfonate (F53B) for 48 h. The results showed that PPARδ deletion abolished CD209 expression, confirming its essential role, whereas PPARα deletion reduced and PPARγ deletion enhanced CD209, indicating PPARα promotes and PPARγ restrains alternative activation. Compounds displayed subtype-selective actions: MEHP activated PPARα/γ; MBzP/MCHP inhibited PPARδ yet activated PPARγ; MINP activated PPARγ only. Among PFAS, PFOS-K activated PPARδ/γ; F53B inhibited PPARα; PFOA activated PPARγ; PFDA inhibited PPARα/δ. Transcriptomics revealed compound-specific enrichments—cholesterol (MEHP), fatty-acid (MCHP), glycolysis (PFOS-K), TCA cycle (PFOA)—despite common PPAR pathway engagement. In conclusion, PAEs and PFAS disrupt macrophage plasticity through distinct PPAR-subtype signatures, providing molecular landmarks for future hazard assessment of environmental pollutants.
邻苯二甲酸酯(PAEs)和全氟烷基和多氟烷基物质(PFAS)是与代谢和免疫紊乱有关的无处不在的污染物。过氧化物酶体增殖物激活受体(PPAR)途径已被证实介导其毒性作用,但PPAR亚型的具体功能及其介导作用尚不清楚。本研究利用CRISPR/Cas9系统生成PPARα-、δ-和γ-特异性敲除THP-1细胞系,并将其分化为白细胞介素-4 (IL-4)和白细胞介素-13 (IL-13)极化的巨噬细胞(交替活化)。在诱导过程中,细胞分别暴露于0、6.25、12.5、25、50、100μM浓度的5种PAE代谢物:邻苯二甲酸一(2-乙基己基)酯(MEHP)、邻苯二甲酸一环己基(MCHP)、邻苯二甲酸一异戊酯(MINP)、邻苯二甲酸一异丁酯(MIBP)和邻苯二甲酸一苯二酯(MBzP);和五种全氟辛烷酸:全氟癸酸(PFUnDA)、全氟癸酸(PFDA)、全氟辛酸(PFOA)、全氟辛烷磺酸钾(PFOS-K)和9-氯十六氟-3-草氧酮-1-磺酸钾(F53B) 48小时。结果表明,PPARδ缺失可消除CD209的表达,证实了其重要作用,而PPARα缺失可减少CD209的表达,而PPARγ缺失可增强CD209的表达,表明PPARα促进和PPARγ抑制替代激活。显示亚型选择性作用的化合物:MEHP激活PPARα/γ;MBzP/MCHP抑制PPARδ但激活PPARγ;MINP仅激活PPARγ。在PFAS中,PFOS-K活化PPARδ/γ;F53B抑制PPARα;PFOA活化PPARγ;PFDA抑制PPARα/δ。转录组学显示,尽管常见的PPAR通路参与,但化合物特异性富集-胆固醇(MEHP),脂肪酸(MCHP),糖酵解(PFOS-K), TCA循环(PFOA)。综上所述,PAEs和PFAS通过不同的ppar亚型特征破坏巨噬细胞的可塑性,为未来环境污染物的危害评估提供了分子标志。
{"title":"PPAR subtypes determine distinct modes of action of phthalate esters (PAEs) and per- and polyfluoroalkyl substances (PFAS) in disrupting human macrophage alternative activation","authors":"Zhisen Zhuang ,&nbsp;Lijuan You ,&nbsp;Jianbo Kong ,&nbsp;Yaru Tian ,&nbsp;Yongning Li ,&nbsp;Yuan Zhi ,&nbsp;Bo Zhang ,&nbsp;Yi Wan ,&nbsp;Xudong Jia ,&nbsp;Hui Yang","doi":"10.1016/j.tox.2025.154387","DOIUrl":"10.1016/j.tox.2025.154387","url":null,"abstract":"<div><div>Phthalate esters (PAEs) and per- and polyfluoroalkyl substances (PFAS) are ubiquitous pollutants tied to metabolic and immune disorders. The peroxisome proliferator-activated receptor (PPAR) pathway has been indicated to mediate their toxic effects, but the specific functions of PPAR subtypes and their mediating roles remain unclear. In this study, we generated PPARα-, δ-, and γ-specific knockout THP-1 cell lines by using CRISPR/Cas9 system and then differentiated them into interleukin-4 (IL-4) and interleukin-13 (IL-13)-polarized macrophages (alternative activation). During the induction process, the cells were exposed to 0, 6.25, 12.5, 25, 50, 100 μM of five PAE metabolites: Mono-(2-ethylhexyl) phthalate (MEHP), Monocyclohexyl phthalate (MCHP), Monoisonyl phthalate (MINP), Monoisobutyl phthalate (MIBP), and Monobenzyl phthalate (MBzP); and five PFAS: Perfluoroundecanoic acid (PFUnDA), Perfluorodecanoic acid (PFDA), Perfluorooctanoic acid (PFOA), Potassium perfluorooctanesulfonate (PFOS-K), and Potassium 9-chlorohexadecafluoro-3-oxanonane-1-sulfonate (F53B) for 48 h. The results showed that PPARδ deletion abolished CD209 expression, confirming its essential role, whereas PPARα deletion reduced and PPARγ deletion enhanced CD209, indicating PPARα promotes and PPARγ restrains alternative activation. Compounds displayed subtype-selective actions: MEHP activated PPARα/γ; MBzP/MCHP inhibited PPARδ yet activated PPARγ; MINP activated PPARγ only. Among PFAS, PFOS-K activated PPARδ/γ; F53B inhibited PPARα; PFOA activated PPARγ; PFDA inhibited PPARα/δ. Transcriptomics revealed compound-specific enrichments—cholesterol (MEHP), fatty-acid (MCHP), glycolysis (PFOS-K), TCA cycle (PFOA)—despite common PPAR pathway engagement. In conclusion, PAEs and PFAS disrupt macrophage plasticity through distinct PPAR-subtype signatures, providing molecular landmarks for future hazard assessment of environmental pollutants.</div></div>","PeriodicalId":23159,"journal":{"name":"Toxicology","volume":"521 ","pages":"Article 154387"},"PeriodicalIF":4.6,"publicationDate":"2025-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145850303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transcriptomic analysis of BPA alternative chemicals in primary human mammary epithelial cells 人乳腺上皮细胞中双酚a替代化学物质的转录组学分析。
IF 4.6 3区 医学 Q1 PHARMACOLOGY & PHARMACY Pub Date : 2025-12-20 DOI: 10.1016/j.tox.2025.154375
Geronimo Matteo , Andrea Rowan-Carroll , Lauren M. Bradford , Matthew J. Meier , Andrew Williams , J. Christopher Corton , Carole L. Yauk , Ella Atlas
Some everyday consumer products contain endocrine disruptors like bisphenol A (BPA) and its replacements. To date, most in vitro chemical screening to evaluate these compounds has been accomplished using immortalized cell lines, which differ significantly from human tissues. Our goal was to test BPA and select alternatives previously screened in breast cancer cells for toxicological potency and mechanism of action in human mammary epithelial cells (HMECs). HMECs from three human donors were exposed to BPA and four alternative chemicals (in concentration response format from 0.001 to 50 µM) for 48 h and global transcriptomic changes were quantified. Transcriptomic biomarker analysis was employed to explore chemically induced estrogen receptor alpha (ERα) activation and alterations in stress response pathways. Benchmark concentration (BMC) analysis was applied to gene expression data to derive transcriptomic points of departure (tPODs) to compare chemicals for potency. Pathway and upstream regulator analysis was applied among the genes fitting BMCs. All chemicals had tPODs within a single order of magnitude. Bisphenol AF (BPAF) was the most potent, followed by tetramethyl bisphenol F (TMBPF), bisphenol C (BPC), 4,4’-bisphenol S (BPS), and BPA. None of the chemicals activated the ERα biomarker. Some stress response biomarkers were activated at high exposure concentrations. Genes fitting BMCs clustered chemicals into two groups, with one group (BPAF and TMBPF) primarily inhibiting expression patterns and the other (BPC, BPS, and BPA) mostly activating. These data suggest that the BPA alternatives tested have similar toxicological potencies in HMECs and oppositely enrich various gene sets.
一些日常消费品含有内分泌干扰物,如双酚A (BPA)及其替代品。迄今为止,大多数评估这些化合物的体外化学筛选都是使用永生化细胞系完成的,这些细胞系与人体组织有很大不同。我们的目标是测试BPA,并选择先前在乳腺癌细胞中筛选的替代品,以研究其在人乳腺上皮细胞(HMECs)中的毒理学效力和作用机制。将来自三名人类供体的hmec暴露于BPA和四种替代化学物质(浓度响应格式为0.001 - 50µM) 48小时,并对全球转录组学变化进行量化。利用转录组学生物标志物分析探讨化学诱导的雌激素受体α (ERα)激活和应激反应途径的改变。基准浓度(BMC)分析应用于基因表达数据,得出转录组起始点(tpod),以比较化学物质的效力。对拟合bmc的基因进行了途径和上游调控分析。所有化学物质的tpod都在一个数量级内。双酚AF (BPAF)最强,其次是四甲基双酚F (TMBPF)、双酚C (BPC)、4,4′-双酚S (BPS)和BPA。没有一种化学物质激活ERα生物标志物。一些应激反应生物标志物在高暴露浓度下被激活。适合bmc的基因将化学物质聚集成两组,其中一组(BPAF和TMBPF)主要抑制表达模式,另一组(BPC, BPS和BPA)主要激活表达模式。这些数据表明,测试的双酚a替代品在hmec中具有相似的毒理学效力,相反地丰富了各种基因集。
{"title":"Transcriptomic analysis of BPA alternative chemicals in primary human mammary epithelial cells","authors":"Geronimo Matteo ,&nbsp;Andrea Rowan-Carroll ,&nbsp;Lauren M. Bradford ,&nbsp;Matthew J. Meier ,&nbsp;Andrew Williams ,&nbsp;J. Christopher Corton ,&nbsp;Carole L. Yauk ,&nbsp;Ella Atlas","doi":"10.1016/j.tox.2025.154375","DOIUrl":"10.1016/j.tox.2025.154375","url":null,"abstract":"<div><div>Some everyday consumer products contain endocrine disruptors like bisphenol A (BPA) and its replacements. To date, most <em>in vitro</em> chemical screening to evaluate these compounds has been accomplished using immortalized cell lines, which differ significantly from human tissues. Our goal was to test BPA and select alternatives previously screened in breast cancer cells for toxicological potency and mechanism of action in human mammary epithelial cells (HMECs). HMECs from three human donors were exposed to BPA and four alternative chemicals (in concentration response format from 0.001 to 50 µM) for 48 h and global transcriptomic changes were quantified. Transcriptomic biomarker analysis was employed to explore chemically induced estrogen receptor alpha (ERα) activation and alterations in stress response pathways. Benchmark concentration (BMC) analysis was applied to gene expression data to derive transcriptomic points of departure (tPODs) to compare chemicals for potency. Pathway and upstream regulator analysis was applied among the genes fitting BMCs. All chemicals had tPODs within a single order of magnitude. Bisphenol AF (BPAF) was the most potent, followed by tetramethyl bisphenol F (TMBPF), bisphenol C (BPC), 4,4’-bisphenol S (BPS), and BPA. None of the chemicals activated the ERα biomarker. Some stress response biomarkers were activated at high exposure concentrations. Genes fitting BMCs clustered chemicals into two groups, with one group (BPAF and TMBPF) primarily inhibiting expression patterns and the other (BPC, BPS, and BPA) mostly activating. These data suggest that the BPA alternatives tested have similar toxicological potencies in HMECs and oppositely enrich various gene sets.</div></div>","PeriodicalId":23159,"journal":{"name":"Toxicology","volume":"521 ","pages":"Article 154375"},"PeriodicalIF":4.6,"publicationDate":"2025-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145811034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A scalable human liver-on-a-chip platform for predictive safety assessment 用于预测安全性评估的可扩展人体肝脏芯片平台。
IF 4.6 3区 医学 Q1 PHARMACOLOGY & PHARMACY Pub Date : 2025-12-19 DOI: 10.1016/j.tox.2025.154378
Gauri Kulkarni , Lizao Chen , Jing Sang , Ji Hye Seo , Romain Grall , Yunfang Wang , Paige Gilbride , Yu-Chieh Yuan , Matthew Albaum-Getzen , Jenna McCormack , Jingzhe Ma , Alyssa Fanelli , Lingjun Meng , Beibei Xu , XuHai Huang , Thomas Marshall , Hardeep Singh , Xiaohua Qian , Zhiyong Xie , Hui Bai , Haiqing Bai
Non-animal methods, including advanced in-vitro approaches such as liver-on-a-chip models, hold promise for hepatotoxicity testing but remain limited in pharmaceutical and regulatory adoption due to high costs, poor scalability, low reproducibility, and insufficient validation. To address these challenges, we introduce a drug-induced liver injury (DILI) model based on the commercially available and highly adaptable OC-Plex microfluidic platform. Primary human hepatocytes (PHHs) maintained long-term viability and metabolic competence, confirmed by albumin and urea production as well as cytochrome P450 gene expression. The system reliably detected acetaminophen (APAP) - induced hepatotoxicity across six mechanistic readouts—albumin, viability, cytokeratin-18 (CK18), urea, CYP3A4 activity, and mitochondrial function. As an initial proof-of-concept, we tested 17 compounds, including both drugs and cosmetic ingredients. Among 13 compounds with known toxicity liabilities in humans, our model shows a high predictive performance (85.7 % sensitivity, 100 % specificity, and 92.3 % accuracy). Together, these findings demonstrate the feasibility of a cost-effective, scalable, and human-relevant liver-on-a-chip system for predictive hepatotoxicity testing. With future development and validation, this model holds great potential to replace animal testing in chemical safety assessment.
非动物方法,包括先进的体外方法,如肝脏芯片模型,有望用于肝毒性测试,但由于成本高、可扩展性差、可重复性低和验证不足,在制药和监管方面的应用仍然有限。为了解决这些挑战,我们介绍了一种基于市售的高适应性OC-Plex微流控平台的药物性肝损伤(DILI)模型。原代人肝细胞(PHHs)维持了长期的活力和代谢能力,白蛋白和尿素的产生以及细胞色素P450基因的表达证实了这一点。该系统通过六个机制读数——白蛋白、活力、细胞角蛋白-18 (CK18)、尿素、CYP3A4活性和线粒体功能,可靠地检测对乙酰氨基酚(APAP)诱导的肝毒性。作为最初的概念验证,我们测试了17种化合物,包括药物和化妆品成分。在13种已知对人体具有毒性的化合物中,我们的模型显示出很高的预测性能(敏感性85.7%,特异性100%,准确性92.3%)。总之,这些发现证明了一种具有成本效益、可扩展且与人类相关的肝脏芯片系统用于预测肝毒性测试的可行性。随着未来的发展和验证,该模型具有取代动物试验进行化学品安全评估的巨大潜力。
{"title":"A scalable human liver-on-a-chip platform for predictive safety assessment","authors":"Gauri Kulkarni ,&nbsp;Lizao Chen ,&nbsp;Jing Sang ,&nbsp;Ji Hye Seo ,&nbsp;Romain Grall ,&nbsp;Yunfang Wang ,&nbsp;Paige Gilbride ,&nbsp;Yu-Chieh Yuan ,&nbsp;Matthew Albaum-Getzen ,&nbsp;Jenna McCormack ,&nbsp;Jingzhe Ma ,&nbsp;Alyssa Fanelli ,&nbsp;Lingjun Meng ,&nbsp;Beibei Xu ,&nbsp;XuHai Huang ,&nbsp;Thomas Marshall ,&nbsp;Hardeep Singh ,&nbsp;Xiaohua Qian ,&nbsp;Zhiyong Xie ,&nbsp;Hui Bai ,&nbsp;Haiqing Bai","doi":"10.1016/j.tox.2025.154378","DOIUrl":"10.1016/j.tox.2025.154378","url":null,"abstract":"<div><div>Non-animal methods, including advanced <em>in-vitro</em> approaches such as liver-on-a-chip models, hold promise for hepatotoxicity testing but remain limited in pharmaceutical and regulatory adoption due to high costs, poor scalability, low reproducibility, and insufficient validation. To address these challenges, we introduce a drug-induced liver injury (DILI) model based on the commercially available and highly adaptable OC-Plex microfluidic platform. Primary human hepatocytes (PHHs) maintained long-term viability and metabolic competence, confirmed by albumin and urea production as well as cytochrome P450 gene expression. The system reliably detected acetaminophen (APAP) - induced hepatotoxicity across six mechanistic readouts—albumin, viability, cytokeratin-18 (CK18), urea, CYP3A4 activity, and mitochondrial function. As an initial proof-of-concept, we tested 17 compounds, including both drugs and cosmetic ingredients. Among 13 compounds with known toxicity liabilities in humans, our model shows a high predictive performance (85.7 % sensitivity, 100 % specificity, and 92.3 % accuracy). Together, these findings demonstrate the feasibility of a cost-effective, scalable, and human-relevant liver-on-a-chip system for predictive hepatotoxicity testing. With future development and validation, this model holds great potential to replace animal testing in chemical safety assessment.</div></div>","PeriodicalId":23159,"journal":{"name":"Toxicology","volume":"521 ","pages":"Article 154378"},"PeriodicalIF":4.6,"publicationDate":"2025-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145805556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the absence of allometric scaling for hepatic microsomal Phase I and Phase II xenobiotic biotransformation among mammals 评估哺乳动物肝微粒体I期和II期异种生物转化中不存在异速缩放。
IF 4.6 3区 医学 Q1 PHARMACOLOGY & PHARMACY Pub Date : 2025-12-18 DOI: 10.1016/j.tox.2025.154377
Luke Ockhuijsen, Ad M.J. Ragas, A. Jan Hendriks
Elucidating consistent patterns for xenobiotic biotransformation among mammals is challenging because of intrinsic species differences. At the organism level, pharmacokinetic rate constants are believed to scale allometrically to body weight with a power of ¾, akin to metabolic rate constants, but the mechanism for biotransformation scaling is unclear. Predicting xenobiotic biotransformation through a quantitative in vitro to in vivo extrapolation (QIVIVE) approach combining allometric scaling relationships related to liver physiology and in vitro xenobiotic biotransformation could be promising. This study explores the previously unexplored potential of allometric scaling for hepatic microsomal Michaelis-Menten parameters. Hepatic microsomal Michaelis-Menten parameters, viz., affinity (Km), maximum velocity (Vmax), and in vitro clearance (CLint), were examined for the xenobiotic biotransformation enzymes Cytochrome P450 (CYP) and UDP-glucuronosyl transferase (UGT). To ensure validity, data for ≥ 4 mammals per substrate biotransformation pathway were collected through a literature search and available databases. Ordinary linear regressions per pathway for each parameter showed that only a few individual regressions scaled statistically significantly to body weight. Averaging all scaling exponents of significant regressions revealed that hepatic microsomal Michaelis-Menten parameters are independent of body weight. Although not statistically significant, the average scaling exponent for each Michaelis-Menten parameter was close to 0. Therefore, differences in enzyme abundance or liver physiology between species are likely contributors to the observed ¾ exponent for allometric scaling relationships of in vivo xenobiotic clearance. Characterisation of underlying mechanisms at an enzyme-substrate level might ultimately improve understanding and estimation of xenobiotic clearance for mammals in QIVIVE approaches.
由于固有的物种差异,阐明哺乳动物之间异种生物转化的一致模式具有挑战性。在机体水平上,药代动力学速率常数被认为与体重成3 / 4的异速比例,类似于代谢速率常数,但生物转化比例的机制尚不清楚。通过结合与肝脏生理学相关的异速缩放关系和体外异种生物转化的定量体外到体内外推法(QIVIVE)预测异种生物转化可能是有前途的。本研究探讨了肝微粒体Michaelis-Menten参数异速缩放的潜力。检测肝微粒体Michaelis-Menten参数,即亲和力(Km)、最大速度(Vmax)和体外清除率(CLint),检测外生生物转化酶细胞色素P450 (CYP)和udp -葡萄糖醛基转移酶(UGT)。为了确保有效性,通过文献检索和现有数据库收集了每种底物生物转化途径中至少4只哺乳动物的数据。对每个参数的每个途径的普通线性回归表明,只有少数个体回归对体重具有统计显著性。对所有显著回归的标度指数进行平均,显示肝微粒体Michaelis-Menten参数与体重无关。虽然没有统计学意义,但每个Michaelis-Menten参数的平均标度指数接近于0。因此,物种之间酶丰度或肝脏生理的差异可能是观察到的体内异种生物清除异速缩放关系的¾指数的贡献者。在酶-底物水平上对潜在机制的描述可能最终提高对QIVIVE方法中哺乳动物外源清除的理解和估计。
{"title":"Evaluating the absence of allometric scaling for hepatic microsomal Phase I and Phase II xenobiotic biotransformation among mammals","authors":"Luke Ockhuijsen,&nbsp;Ad M.J. Ragas,&nbsp;A. Jan Hendriks","doi":"10.1016/j.tox.2025.154377","DOIUrl":"10.1016/j.tox.2025.154377","url":null,"abstract":"<div><div>Elucidating consistent patterns for xenobiotic biotransformation among mammals is challenging because of intrinsic species differences. At the organism level, pharmacokinetic rate constants are believed to scale allometrically to body weight with a power of ¾, akin to metabolic rate constants, but the mechanism for biotransformation scaling is unclear. Predicting xenobiotic biotransformation through a quantitative <em>in vitro</em> to <em>in vivo</em> extrapolation (QIVIVE) approach combining allometric scaling relationships related to liver physiology and <em>in vitro</em> xenobiotic biotransformation could be promising. This study explores the previously unexplored potential of allometric scaling for hepatic microsomal Michaelis-Menten parameters. Hepatic microsomal Michaelis-Menten parameters, viz., affinity (K<sub>m</sub>), maximum velocity (V<sub>max</sub>), and <em>in vitro</em> clearance (CL<sub>int</sub>), were examined for the xenobiotic biotransformation enzymes Cytochrome P450 (CYP) and UDP-glucuronosyl transferase (UGT). To ensure validity, data for ≥ 4 mammals per substrate biotransformation pathway were collected through a literature search and available databases. Ordinary linear regressions per pathway for each parameter showed that only a few individual regressions scaled statistically significantly to body weight. Averaging all scaling exponents of significant regressions revealed that hepatic microsomal Michaelis-Menten parameters are independent of body weight. Although not statistically significant, the average scaling exponent for each Michaelis-Menten parameter was close to 0. Therefore, differences in enzyme abundance or liver physiology between species are likely contributors to the observed ¾ exponent for allometric scaling relationships of <em>in vivo</em> xenobiotic clearance. Characterisation of underlying mechanisms at an enzyme-substrate level might ultimately improve understanding and estimation of xenobiotic clearance for mammals in QIVIVE approaches.</div></div>","PeriodicalId":23159,"journal":{"name":"Toxicology","volume":"521 ","pages":"Article 154377"},"PeriodicalIF":4.6,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145800627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neurotoxic potential of synthetic cannabinoids’ pyrolysis products 合成大麻素热解产物的神经毒性潜力
IF 4.6 3区 医学 Q1 PHARMACOLOGY & PHARMACY Pub Date : 2025-12-18 DOI: 10.1016/j.tox.2025.154374
Filipa Pita , Ricardo Jorge Dinis-Oliveira , João Pedro Silva , Paula Guedes de Pinho , Félix Carvalho
Synthetic cannabinoids (SCs) represent a prominent class of new psychoactive substances (NPS), primarily consumed via inhalation methods such as smoking or vaping. Although the direct neurotoxic effects of SCs are well established, the pyrolysis process that occurs during smoking induces structural alterations that generate novel, frequently unidentified toxicants with potentially severe neurobiological consequences. This review addresses the neurotoxicity associated with parent SC compounds and their pyrolysis products, with particular emphasis on mechanisms, including oxidative stress, mitochondrial dysfunction, excitotoxicity, and neuroinflammation. A PRISMA-guided systematic review identified only nine studies specifically investigating the neurotoxic effects of SC pyrolysis products, revealing a significant gap in the literature and underscoring the urgent need for targeted research in this domain. The review further highlights that additional constituents, such as plant materials incorporated into SC formulations, can contribute to the generation of harmful byproducts and complicate forensic interpretation. The structural heterogeneity of SCs, in conjunction with variables such as polydrug use and chronic exposure, further exacerbates their toxicological profile. Future research should prioritise the identification and characterisation of pyrolysis-derived toxicants, the advancement of analytical methodologies for their detection, and the implementation of evidence-based public health strategies aimed at risk mitigation.
合成大麻素(SCs)是一类突出的新型精神活性物质(NPS),主要通过吸烟或电子烟等吸入方式消耗。虽然sc的直接神经毒性作用已经得到了很好的证实,但吸烟过程中发生的热解过程会诱导结构改变,从而产生新的、经常未知的有毒物质,并可能产生严重的神经生物学后果。本文综述了与母体SC化合物及其热解产物相关的神经毒性,特别强调了其机制,包括氧化应激、线粒体功能障碍、兴奋性毒性和神经炎症。一项prisma引导的系统综述发现,只有9项研究专门研究了SC热解产物的神经毒性作用,这揭示了文献中的重大空白,并强调了该领域有针对性研究的迫切需要。该综述进一步强调,添加到SC制剂中的其他成分,如植物材料,可能导致有害副产品的产生,并使法医解释复杂化。SCs的结构异质性,加上多种药物使用和慢性暴露等变量,进一步加剧了它们的毒理学特征。未来的研究应优先考虑鉴定和鉴定热解衍生毒物,改进检测这些毒物的分析方法,以及实施旨在减轻风险的循证公共卫生战略。
{"title":"Neurotoxic potential of synthetic cannabinoids’ pyrolysis products","authors":"Filipa Pita ,&nbsp;Ricardo Jorge Dinis-Oliveira ,&nbsp;João Pedro Silva ,&nbsp;Paula Guedes de Pinho ,&nbsp;Félix Carvalho","doi":"10.1016/j.tox.2025.154374","DOIUrl":"10.1016/j.tox.2025.154374","url":null,"abstract":"<div><div>Synthetic cannabinoids (SCs) represent a prominent class of new psychoactive substances (NPS), primarily consumed via inhalation methods such as smoking or vaping. Although the direct neurotoxic effects of SCs are well established, the pyrolysis process that occurs during smoking induces structural alterations that generate novel, frequently unidentified toxicants with potentially severe neurobiological consequences. This review addresses the neurotoxicity associated with parent SC compounds and their pyrolysis products, with particular emphasis on mechanisms, including oxidative stress, mitochondrial dysfunction, excitotoxicity, and neuroinflammation. A PRISMA-guided systematic review identified only nine studies specifically investigating the neurotoxic effects of SC pyrolysis products, revealing a significant gap in the literature and underscoring the urgent need for targeted research in this domain. The review further highlights that additional constituents, such as plant materials incorporated into SC formulations, can contribute to the generation of harmful byproducts and complicate forensic interpretation. The structural heterogeneity of SCs, in conjunction with variables such as polydrug use and chronic exposure, further exacerbates their toxicological profile. Future research should prioritise the identification and characterisation of pyrolysis-derived toxicants, the advancement of analytical methodologies for their detection, and the implementation of evidence-based public health strategies aimed at risk mitigation.</div></div>","PeriodicalId":23159,"journal":{"name":"Toxicology","volume":"521 ","pages":"Article 154374"},"PeriodicalIF":4.6,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145799682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PM2.5 exposure exacerbates airway pyroptosis related inflammatory response in asthmatic mice by activating NLRP3 inflammasome PM2.5暴露通过激活NLRP3炎性体加剧哮喘小鼠气道焦亡相关炎症反应。
IF 4.6 3区 医学 Q1 PHARMACOLOGY & PHARMACY Pub Date : 2025-12-18 DOI: 10.1016/j.tox.2025.154376
Hui Du , Zhi Liu , Lingli Ge , Yuxi Lei , Yuxin Wang , Jian Lan , Dongchi Zhao

Background

Fine particulate matter (PM2.5)-induced airway epithelial damage plays a pivotal role in driving the development of airway inflammation. Although pyroptosis is recognized for its highly proinflammatory nature, its precise role in PM2.5-associated airway inflammation, particularly in asthmatic condition, remains to be fully elucidated.

Methods

In ovalbumin (OVA)-sensitized asthmatic mice, we assessed pulmonary histopathology, inflammatory cell counts and Th2 cytokine levels (IL-4, IL-5, and IL-13) in bronchoalveolar lavage fluid (BALF), airway hyperresponsiveness (AHR), and airway epithelial pyroptosis. To investigate the effects of PM2.5 on airway epithelial cells, BEAS-2B cells were exposed to PM2.5. Cell viability was evaluated using the CCK-8 assay, while pyroptosis-related protein levels and inflammatory cytokine release were analyzed by Western blot and ELISA, respectively. Additionally, transmission electron microscopy (TEM) was employed to examine PM2.5-induced ultrastructural changes in BEAS-2B cells. To further elucidate the underlying mechanism, we administered the NLRP3 inhibitor MCC950 and the Caspase-1 inhibitor Ac-YVAD-cmk to verify the involvement of NLRP3 inflammasome activation and pyroptosis in PM2.5-exposed asthmatic mice.

Results

PM2.5 exposure significantly aggravated airway inflammation in asthmatic mice, as demonstrated by elevated histopathological inflammatory scores in lung tissues and increased pro-inflammatory cytokine levels in BALF. Furthermore, PM2.5 upregulated the abundance of pyroptosis-related markers, namely NLRP3, Caspase-1, GSDMD, and IL-1β, in the lung tissues of asthmatic mice. In BEAS-2B cells, PM2.5 exposure led to a dose-dependent reduction in cell viability and promoted the activation of NLRP3 inflammasome, subsequently leading to Caspase-1-mediated GSDMD cleavage and IL-1β secretion. TEM further confirmed pyroptosis, revealing characteristic morphological alterations such as cytoplasmic vacuolation, mitochondrial swelling, and plasma membrane pore formation in BEAS-2B cells exposed to PM2.5. Critically, inhibition of NLRP3 (MCC950) or Caspase-1 (Ac-YVAD-cmk) markedly attenuated PM2.5-induced pyroptosis and ameliorated airway inflammation in asthmatic mice, underscoring the pivotal role of the NLRP3/Caspase-1/GSDMD axis in this pathogenic process.

Conclusion

Our findings demonstrate that PM2.5 exposure induces airway epithelial pyroptosis through NLRP3 inflammasome activation, thereby exacerbating airway inflammation in asthmatic mice.
背景:细颗粒物(PM2.5)诱导的气道上皮损伤在气道炎症的发展中起着关键作用。虽然焦亡被认为具有高度促炎的性质,但其在pm2.5相关气道炎症中的确切作用,特别是在哮喘条件下,仍有待充分阐明。方法:在卵清蛋白(OVA)致敏的哮喘小鼠中,我们评估了肺组织病理学、支气管肺泡灌洗液(BALF)中炎症细胞计数和Th2细胞因子(IL-4、IL-5和IL-13)水平、气道高反应性(AHR)和气道上皮焦亡。为了研究PM2.5对气道上皮细胞的影响,我们将BEAS-2B细胞暴露于PM2.5中。采用CCK-8法评估细胞活力,Western blot和ELISA法分别分析热释热相关蛋白水平和炎症细胞因子释放。透射电镜(TEM)观察pm2.5对BEAS-2B细胞超微结构的影响。为了进一步阐明其潜在机制,我们给药NLRP3抑制剂MCC950和Caspase-1抑制剂Ac-YVAD-cmk,以验证暴露于pm2.5的哮喘小鼠NLRP3炎性体激活和焦亡的参与。结果:PM2.5暴露显著加重哮喘小鼠气道炎症,肺组织组织病理学炎症评分升高,BALF促炎细胞因子水平升高。此外,PM2.5上调了哮喘小鼠肺组织中与热相关的标志物NLRP3、Caspase-1、GSDMD和IL-1β的丰度。在BEAS-2B细胞中,PM2.5暴露导致细胞活力呈剂量依赖性降低,并促进NLRP3炎性体的激活,随后导致caspase -1介导的GSDMD裂解和IL-1β分泌。透射电镜进一步证实了PM2.5暴露的BEAS-2B细胞的热凋亡,揭示了细胞质空泡化、线粒体肿胀和质膜孔形成等特征性形态学改变。重要的是,抑制NLRP3 (MCC950)或Caspase-1 (Ac-YVAD-cmk)可显著减轻pm2.5诱导的哮喘小鼠焦亡和改善气道炎症,强调了NLRP3/Caspase-1/GSDMD轴在这一致病过程中的关键作用。结论:我们的研究结果表明,PM2.5暴露通过NLRP3炎性体激活诱导哮喘小鼠气道上皮焦亡,从而加剧气道炎症。
{"title":"PM2.5 exposure exacerbates airway pyroptosis related inflammatory response in asthmatic mice by activating NLRP3 inflammasome","authors":"Hui Du ,&nbsp;Zhi Liu ,&nbsp;Lingli Ge ,&nbsp;Yuxi Lei ,&nbsp;Yuxin Wang ,&nbsp;Jian Lan ,&nbsp;Dongchi Zhao","doi":"10.1016/j.tox.2025.154376","DOIUrl":"10.1016/j.tox.2025.154376","url":null,"abstract":"<div><h3>Background</h3><div>Fine particulate matter (PM2.5)-induced airway epithelial damage plays a pivotal role in driving the development of airway inflammation. Although pyroptosis is recognized for its highly proinflammatory nature, its precise role in PM2.5-associated airway inflammation, particularly in asthmatic condition, remains to be fully elucidated.</div></div><div><h3>Methods</h3><div>In ovalbumin (OVA)-sensitized asthmatic mice, we assessed pulmonary histopathology, inflammatory cell counts and Th2 cytokine levels (IL-4, IL-5, and IL-13) in bronchoalveolar lavage fluid (BALF), airway hyperresponsiveness (AHR), and airway epithelial pyroptosis. To investigate the effects of PM2.5 on airway epithelial cells, BEAS-2B cells were exposed to PM2.5. Cell viability was evaluated using the CCK-8 assay, while pyroptosis-related protein levels and inflammatory cytokine release were analyzed by Western blot and ELISA, respectively. Additionally, transmission electron microscopy (TEM) was employed to examine PM2.5-induced ultrastructural changes in BEAS-2B cells. To further elucidate the underlying mechanism, we administered the NLRP3 inhibitor MCC950 and the Caspase-1 inhibitor Ac-YVAD-cmk to verify the involvement of NLRP3 inflammasome activation and pyroptosis in PM2.5-exposed asthmatic mice.</div></div><div><h3>Results</h3><div>PM2.5 exposure significantly aggravated airway inflammation in asthmatic mice, as demonstrated by elevated histopathological inflammatory scores in lung tissues and increased pro-inflammatory cytokine levels in BALF. Furthermore, PM2.5 upregulated the abundance of pyroptosis-related markers, namely NLRP3, Caspase-1, GSDMD, and IL-1β, in the lung tissues of asthmatic mice. In BEAS-2B cells, PM2.5 exposure led to a dose-dependent reduction in cell viability and promoted the activation of NLRP3 inflammasome, subsequently leading to Caspase-1-mediated GSDMD cleavage and IL-1β secretion. TEM further confirmed pyroptosis, revealing characteristic morphological alterations such as cytoplasmic vacuolation, mitochondrial swelling, and plasma membrane pore formation in BEAS-2B cells exposed to PM2.5. Critically, inhibition of NLRP3 (MCC950) or Caspase-1 (Ac-YVAD-cmk) markedly attenuated PM2.5-induced pyroptosis and ameliorated airway inflammation in asthmatic mice, underscoring the pivotal role of the NLRP3/Caspase-1/GSDMD axis in this pathogenic process.</div></div><div><h3>Conclusion</h3><div>Our findings demonstrate that PM2.5 exposure induces airway epithelial pyroptosis through NLRP3 inflammasome activation, thereby exacerbating airway inflammation in asthmatic mice.</div></div>","PeriodicalId":23159,"journal":{"name":"Toxicology","volume":"521 ","pages":"Article 154376"},"PeriodicalIF":4.6,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145800687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mixture toxicity revisited: A translational review of experimental evidence from animal models to human health risk assessment 混合物毒性重新审视:从动物模型到人类健康风险评估的实验证据的转化评论。
IF 4.6 3区 医学 Q1 PHARMACOLOGY & PHARMACY Pub Date : 2025-12-14 DOI: 10.1016/j.tox.2025.154372
Jose L. Domingo
This review examines research investigating how simultaneous exposure to multiple chemicals affects biological systems, highlighting deficiencies in conventional single-substance risk evaluation frameworks. Living organisms in their natural habitats face continuous exposure to diverse chemical combinations, which frequently result in interactive effects, including synergism and antagonism, that diverge from the straightforward additive outcomes anticipated by traditional toxicological approaches. Research using animal and aquatic experimental models has shown that these exposures depend on numerous variables, such as the specific chemicals involved, their dose relationships, duration of contact, measured biological outcomes, and underlying mechanistic processes. This review examines fundamental methodological frameworks, particularly concentration addition (CA) and independent action (IA) models, used for predicting mixture toxicity, with most mixture effects falling within a two-fold range of additivity predictions though important deviations occur. Additional complicating factors include the timing of exposure and the specific biological traits of test species. The present review also addresses difficulties in applying findings from animal research to human populations, given differences in toxicokinetic processes and genetic makeup across species. To navigate these complexities, this review supports the adoption of mechanism-based frameworks incorporating high-throughput omics technologies, computational approaches, and standardized protocols for evaluating environmentally realistic mixtures. The review advocates for implementing tiered, cumulative risk-assessment methodologies that accurately represent real-world exposure conditions and emphasize protection of susceptible populations. This transformation is vital for advancing predictive toxicology and strengthening protections for public and environmental health. Ultimately, the review argues for moving beyond the obsolete single-substance paradigm toward comprehensive, evidence-driven approaches equipped to handle the multifaceted nature of chemical exposures. This review critically evaluates experimental animal studies in chemical mixture toxicology, emphasizing the complexities and prospects of applying animal findings to human health risk assessment. It identifies key gaps linking controlled experiments with epidemiological data and proposes research directions to advance risk evaluation and management of real-world chemical co-exposures.
本综述审查了调查同时暴露于多种化学物质如何影响生物系统的研究,突出了传统单一物质风险评估框架的缺陷。生活在自然栖息地的生物体面临着不断接触各种化学组合的风险,这些化学组合经常导致相互作用,包括协同作用和拮抗作用,这与传统毒理学方法所预期的直接添加性结果不同。利用动物和水生实验模型进行的研究表明,这些暴露取决于许多变量,例如所涉及的特定化学品、它们的剂量关系、接触持续时间、测量的生物学结果和潜在的机制过程。本文回顾了用于预测混合物毒性的基本方法框架,特别是浓度添加(CA)和独立作用(IA)模型,尽管存在重要偏差,但大多数混合物效应都在可加性预测的两倍范围内。其他复杂的因素包括暴露的时间和试验物种的特定生物学特性。鉴于不同物种的毒性动力学过程和基因组成的差异,本综述还讨论了将动物研究结果应用于人类群体的困难。为了应对这些复杂性,本综述支持采用基于机制的框架,结合高通量组学技术、计算方法和标准化协议来评估环境现实的混合物。该综述提倡采用分层累积的风险评估方法,以准确反映真实世界的暴露条件,并强调对易感人群的保护。这一转变对于推进预测毒理学和加强对公众和环境健康的保护至关重要。最后,该评论认为,应超越过时的单一物质范式,转向全面的、证据驱动的方法,以处理化学品暴露的多面性。本综述批判性地评价了化学混合物毒理学的实验动物研究,强调了将动物研究结果应用于人类健康风险评估的复杂性和前景。它确定了将对照实验与流行病学数据联系起来的关键差距,并提出了研究方向,以推进现实世界化学品共同暴露的风险评估和管理。
{"title":"Mixture toxicity revisited: A translational review of experimental evidence from animal models to human health risk assessment","authors":"Jose L. Domingo","doi":"10.1016/j.tox.2025.154372","DOIUrl":"10.1016/j.tox.2025.154372","url":null,"abstract":"<div><div>This review examines research investigating how simultaneous exposure to multiple chemicals affects biological systems, highlighting deficiencies in conventional single-substance risk evaluation frameworks. Living organisms in their natural habitats face continuous exposure to diverse chemical combinations, which frequently result in interactive effects, including synergism and antagonism, that diverge from the straightforward additive outcomes anticipated by traditional toxicological approaches. Research using animal and aquatic experimental models has shown that these exposures depend on numerous variables, such as the specific chemicals involved, their dose relationships, duration of contact, measured biological outcomes, and underlying mechanistic processes. This review examines fundamental methodological frameworks, particularly concentration addition (CA) and independent action (IA) models, used for predicting mixture toxicity, with most mixture effects falling within a two-fold range of additivity predictions though important deviations occur. Additional complicating factors include the timing of exposure and the specific biological traits of test species. The present review also addresses difficulties in applying findings from animal research to human populations, given differences in toxicokinetic processes and genetic makeup across species. To navigate these complexities, this review supports the adoption of mechanism-based frameworks incorporating high-throughput omics technologies, computational approaches, and standardized protocols for evaluating environmentally realistic mixtures. The review advocates for implementing tiered, cumulative risk-assessment methodologies that accurately represent real-world exposure conditions and emphasize protection of susceptible populations. This transformation is vital for advancing predictive toxicology and strengthening protections for public and environmental health. Ultimately, the review argues for moving beyond the obsolete single-substance paradigm toward comprehensive, evidence-driven approaches equipped to handle the multifaceted nature of chemical exposures. This review critically evaluates experimental animal studies in chemical mixture toxicology, emphasizing the complexities and prospects of applying animal findings to human health risk assessment. It identifies key gaps linking controlled experiments with epidemiological data and proposes research directions to advance risk evaluation and management of real-world chemical co-exposures.</div></div>","PeriodicalId":23159,"journal":{"name":"Toxicology","volume":"520 ","pages":"Article 154372"},"PeriodicalIF":4.6,"publicationDate":"2025-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145769309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prenatal diesel exhaust exposure enhances neonatal hyperoxia-induced kidney injury via oxidative stress and lipid disruption 产前柴油机废气暴露通过氧化应激和脂质破坏增强新生儿高氧诱导的肾损伤。
IF 4.6 3区 医学 Q1 PHARMACOLOGY & PHARMACY Pub Date : 2025-12-13 DOI: 10.1016/j.tox.2025.154373
Sheng-Yuan Ho , Yu-Shan Chang , Hsiu-Chu Chou , Chung-Ming Chen
Prenatal exposure to diesel exhaust particles (DEP) and postnatal oxygen therapy are both clinically relevant perinatal stressors, but their combined effects on kidney development are not well characterized. Using a rat model (Sprague Dawley, n = 10/group), pregnant dams received DEP via intranasal instillation (500 μg/day in PBS, gestational day 16–21; NIST SRM 2975), and offspring were maintained in either room air or 85 % oxygen chambers from birth through postnatal day 14. At postnatal day 14, kidneys were analyzed by histology, Western blot, ELISA, and LC-MS metabolomics. Offspring that received both prenatal DEP and postnatal oxygen showed more severe tubular injury across sexes, and higher kidney-to-body weight ratios that were driven primarily by significant increases in male offspring, whereas changes in females did not reach statistical significance. Kidney injury molecule-1 (KIM-1) and 8-hydroxy-2′-deoxyguanosine (8-OHdG) levels were increased, and 8-OHdG showed a significant interaction between DEP and oxygen exposure. Interleukin-1 (IL-1), IL-6, and tumor necrosis factor-α (TNF-α) were elevated by both DEP and oxygen, indicating additive effects. Serum cystatin C, a marker of renal dysfunction, was also increased in all exposed groups and was highest in the dual-exposure group. Cystatin C levels showed strong positive correlations with renal levels of IL-1, IL-6, and TNF-α. Untargeted metabolomics revealed changes in glycerophospholipid metabolism that were specific to the group exposed to both DEP and oxygen. These results suggest that prenatal DEP exposure may increase renal sensitivity to postnatal oxidative stress, pointing to a time-sensitive window of vulnerability during early kidney development.
产前柴油机尾气颗粒暴露(DEP)和产后氧治疗都是临床相关的围产期应激源,但它们对肾脏发育的综合影响尚未得到很好的表征。使用大鼠模型(Sprague Dawley, n = 10/组),怀孕的母鼠通过鼻内滴注DEP (500μg/d, PBS,妊娠16-21天;NIST SRM 2975),后代从出生到出生后14天保持在室内空气或85%氧气舱中。出生后第14天,通过组织学、Western blot、ELISA和LC-MS代谢组学分析肾脏。同时接受产前DEP和产后氧气治疗的后代在性别上表现出更严重的肾小管损伤,并且肾脏体重比更高,这主要是由雄性后代显著增加引起的,而雌性后代的变化没有达到统计学意义。肾损伤分子-1 (KIM-1)和8-羟基-2′-脱氧鸟苷(8-OHdG)水平升高,8-OHdG在DEP和氧暴露之间表现出显著的相互作用。DEP和氧均升高了白细胞介素-1 (IL-1)、IL-6和肿瘤坏死因子-α (TNF-α),表明两者具有叠加作用。血清胱抑素C(肾功能障碍的标志)在所有暴露组中也有所增加,在双重暴露组中最高。胱抑素C水平与肾脏IL-1、IL-6、TNF-α水平呈显著正相关。非靶向代谢组学揭示了甘油磷脂代谢的变化,这是暴露于DEP和氧气的组所特有的。这些结果表明,产前暴露于DEP可能会增加肾脏对产后氧化应激的敏感性,这表明肾脏发育早期存在一个时间敏感的易感性窗口。
{"title":"Prenatal diesel exhaust exposure enhances neonatal hyperoxia-induced kidney injury via oxidative stress and lipid disruption","authors":"Sheng-Yuan Ho ,&nbsp;Yu-Shan Chang ,&nbsp;Hsiu-Chu Chou ,&nbsp;Chung-Ming Chen","doi":"10.1016/j.tox.2025.154373","DOIUrl":"10.1016/j.tox.2025.154373","url":null,"abstract":"<div><div>Prenatal exposure to diesel exhaust particles (DEP) and postnatal oxygen therapy are both clinically relevant perinatal stressors, but their combined effects on kidney development are not well characterized. Using a rat model (Sprague Dawley, n = 10/group), pregnant dams received DEP via intranasal instillation (500 μg/day in PBS, gestational day 16–21; NIST SRM 2975), and offspring were maintained in either room air or 85 % oxygen chambers from birth through postnatal day 14. At postnatal day 14, kidneys were analyzed by histology, Western blot, ELISA, and LC-MS metabolomics. Offspring that received both prenatal DEP and postnatal oxygen showed more severe tubular injury across sexes, and higher kidney-to-body weight ratios that were driven primarily by significant increases in male offspring, whereas changes in females did not reach statistical significance. Kidney injury molecule-1 (KIM-1) and 8-hydroxy-2′-deoxyguanosine (8-OHdG) levels were increased, and 8-OHdG showed a significant interaction between DEP and oxygen exposure. Interleukin-1 (IL-1), IL-6, and tumor necrosis factor-α (TNF-α) were elevated by both DEP and oxygen, indicating additive effects. Serum cystatin C, a marker of renal dysfunction, was also increased in all exposed groups and was highest in the dual-exposure group. Cystatin C levels showed strong positive correlations with renal levels of IL-1, IL-6, and TNF-α. Untargeted metabolomics revealed changes in glycerophospholipid metabolism that were specific to the group exposed to both DEP and oxygen. These results suggest that prenatal DEP exposure may increase renal sensitivity to postnatal oxidative stress, pointing to a time-sensitive window of vulnerability during early kidney development.</div></div>","PeriodicalId":23159,"journal":{"name":"Toxicology","volume":"520 ","pages":"Article 154373"},"PeriodicalIF":4.6,"publicationDate":"2025-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145763870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Toxicology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1